James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Ford Stock: All You Need to Know Before Earnings (F)

Ford stock may be proven as an underestimated, undervalued opportunity if the Ford earnings report is simply "pretty good."

Why Whirlpool Corporation (WHR), Stericycle Inc (SRCL) and VF Corp. (VFC) Are 3 of Today’s Worst Stocks

Too bad for Whirlpool (WHR), Stericycle (SRCL) and VF Corp. (VFC) the market doesn't do do-overs. Here's what investors need to know.

PG Stock: Maybe a Great Trade Right Now, But Still a Wobbly Investment

Kudos to Procter & Gamble for a respectable earnings beat, but before anybody plows into PG stocks for the long haul...

Alphabet Inc Earnings Are Great, But GOOGL Stock Too Pricey Now

Would-be investors in GOOGL stock may want to bide their time before jumping in -- valuation is a big concern at this time despite stellar fiscal results.

Why Valeant Pharmaceuticals Intl. Inc (VRX), American Express Company (AXP) and Community Health Systems (CYH) Are 3 of Today’s Worst Stocks

Valeant Pharmaceuticals (VRX), American Express (AXP) and Community Health Systems (CYH) were destroyed on Thursday for a myriad (but completely understandable) reasons. Here's what investors need to know.